BPCE
CSTL icon

Bank Pictet & Cie (Europe)’s Castle Biosciences CSTL Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,897
Closed -$286K – 162
2024
Q1 		$286K Sell
12,897
-666
-5% -$14.5K 0.01% 150
2023
Q4 		$293K Sell
13,563
-516
-4% -$9.08K 0.01% 229
2023
Q3 		$238K Buy
14,079
+1,813
+15% +$31.7K 0.01% 238
2023
Q2 		$168K Sell
12,266
-474
-4% -$9.61K 0.01% 255
2023
Q1 		$289K Buy
12,740
+122
+1% +$2.98K 0.01% 153
2022
Q4 		$297K Sell
12,618
-3,339
-21% -$77.4K 0.01% 146
2022
Q3 		$416K Buy
+15,957
New +$447K 0.02% 125
2022
Q2 		– Sell
-10,724
Closed -$481K – 164
2022
Q1 		$481K Buy
10,724
+1,035
+11% +$42.8K 0.02% 127
2021
Q4 		$415K Buy
9,689
+1,065
+12% +$55.6K 0.01% 138
2021
Q3 		$574K Sell
8,624
-762
-8% -$53.6K 0.02% 125
2021
Q2 		$688K Buy
9,386
+1,266
+16% +$83.6K 0.02% 120
2021
Q1 		$556K Buy
+8,120
New +$610K 0.02% 122

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s CSTL Position: Q2 2024 in Review

Bank Pictet & Cie (Europe) sold out of Castle Biosciences (CSTL) in Q2 2024, closing a stake of 12,897 shares — an estimated $286K sold.

Bank Pictet & Cie (Europe) first reported a position in CSTL in Q1 2021 and held it in 12 quarters. The position peaked at $688K in Q2 2021. 159 funds tracked by Wall St. Rank hold CSTL as of Q2 2024.

  • Bank Pictet & Cie (Europe) reported no remaining Castle Biosciences position as of Q2 2024 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 12,897 Castle Biosciences shares in Q2 2024, an estimated $286K.
  • Bank Pictet & Cie (Europe) first reported a position in Castle Biosciences in Q1 2021 and held it in 12 quarters.
  • Bank Pictet & Cie (Europe)'s Castle Biosciences position peaked at $688K in Q2 2021.
  • 159 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2024.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2024, filed 25 Jul 2024.